This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Renovascular disease

Authoring team

This condition may result in secondary hypertension and secondary hyperaldosteronism. Other possible features include:

  • coexistant cerebrovascular, cardiovascular or peripheral vascular disease
  • deterioration of renal function following treatment with ACE inhibitor
  • abdominal bruit; signs of coexistant vascular disease e.g. carotid or femoral bruit; absent peripheral pulses

A small kidney will be seen on intravenous urography on the affected side with a delayed and persistent nephrogram (1)

RAS is predominantly due to atherosclerosis (>90%) in the adult population (2)

  • with fibromuscular dysplasia (FMD) being more common in younger female patients

In consideration of computed tomographic angiography and magnetic resonance angiography (MRA) in comparison to digital subtraction angiography (DSA) in diagnosis of renal artery stenosis (1):

  • computed tomographic angiography and MRA are not reproducible or sensitive enough to rule out renal artery stenosis in hypertensive patients
  • DSA is the diagnostic method of choice

Reference:

  1. Vasbinder GB et al. Accuracy of computed tomographic angiography and magnetic resonace angiography for diagnosis renal artery stenosis. Ann Intern Med 2004;141:674-82
  2. de Leeuw PW, Postma CT, Spiering W, Kroon AA. Atherosclerotic Renal Artery Stenosis: Should we Intervene Earlier? Curr Hypertens Rep. 2018 Apr 10;20(4):35

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.